Joseph F. Fowler

Dermatology

501 S 2nd St
Louisville, KY 40202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 142 publications

Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study.

Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study.

Journal: Journal of the American Academy of Dermatology

Published: April 22, 2025

Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?

Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?

Journal: The Journal of dermatological treatment

Published: April 21, 2025

Updated expert opinion guidelines regarding the effects of immunosuppressive agents on patch testing.

Updated expert opinion guidelines regarding the effects of immunosuppressive agents on patch testing.

Journal: Journal of the American Academy of Dermatology

Published: September 17, 2024

Patch Testing With Nickel, Cobalt, and Chromium in Patients With Suspected Allergic Contact Dermatitis.

Patch Testing With Nickel, Cobalt, and Chromium in Patients With Suspected Allergic Contact Dermatitis.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: December 05, 2023

Patch Testing With Cobalt in Adults: A North American Contact Dermatitis Group Experience, 2001-2018.

Patch Testing With Cobalt in Adults: A North American Contact Dermatitis Group Experience, 2001-2018.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: May 19, 2023

Patch Testing With Benzophenone-3 and -4: The North American Contact Dermatitis Group Experience, 2013-2020.

Patch Testing With Benzophenone-3 and -4: The North American Contact Dermatitis Group Experience, 2013-2020.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: March 14, 2023

North American Contact Dermatitis Group Patch Test Results: 2019-2020.

North American Contact Dermatitis Group Patch Test Results: 2019-2020.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: March 14, 2023

Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe.

Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe.

Journal: JAMA dermatology

Published: January 18, 2023

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.

Journal: Dermatology and therapy

Published: October 26, 2022

Co-reactivity of glucosides: Retrospective analysis of North American Contact Dermatitis Group Data 2019-2020.

Co-reactivity of glucosides: Retrospective analysis of North American Contact Dermatitis Group Data 2019-2020.

Journal: Contact dermatitis

Published: August 16, 2022

Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001-2018.

Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001-2018.

Journal: Contact dermatitis

Published: August 07, 2022

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study.

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study.

Journal: Journal of the American Academy of Dermatology

Published: June 13, 2022

Showing 1-12 of 142

Last Updated: 09/26/2026